Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease
Therapeutic Drug Monitoring
Trough Concentration
Trough level
DOI:
10.1007/s40262-024-01354-7
Publication Date:
2024-03-15T13:01:41Z
AUTHORS (7)
ABSTRACT
Efficacy of infliximab in children with inflammatory bowel disease can be enhanced when serum concentrations are measured and further dosing is adjusted to achieve maintain a target concentration. Use population pharmacokinetic model may help predict an individual's dose requirement. The aim this study was evaluate the predictive performance available models independent cohort Dutch disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....